PortViewPortView
Illumina logo

Illumina (ILMN) Stock Analysis

NASDAQHealth CareLife Sciences Tools

$212.95+2.81%
1-year price historyRange $91.00 – $227.69
52-week range$212.95
$88.00$231.81

What Illumina does

Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, and innovative new domains. Illumina's portfolio encompasses specialized instrumentation and necessary consumables for genetic analysis, alongside comprehensive genotyping and sequencing services. They also offer instrument maintenance agreements, collaborate through development and licensing deals, and perform cancer detection tests. Its diverse clientele comprises leading genomic research facilities, universities, state-funded laboratories, medical centers, pharmaceutical and biotechnology firms, commercial molecular diagnostic providers, and businesses focused on consumer genomics. Illumina employs a two-pronged distribution strategy, selling directly to clients across North America, Europe, Latin America, and the Asia-Pacific. Additionally, it partners with life-science distributors to reach markets in Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. Established in 1998, the company maintains its corporate headquarters in San Diego, California.

Key metrics

Market cap
$32.22B
P/E (TTM)
42.33
EPS (TTM)
$5.03
Beta
1.46
Dividend yield
0.00%
Revenue / share
$29.75
50-day avg
$195.47
200-day avg
$150.41
52-week high
$231.81
52-week low
$88.00
CEO
Jacob Thaysen

ETFs linked to ILMN

Broad-market and Health Care sector ETFs an investor holding Illumina is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ILMN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ILMN in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Illumina?
Illumina trades under the ticker ILMN on NASDAQ.
Which exchange is ILMN listed on?
ILMN is listed on NASDAQ.
What sector does Illumina operate in?
Illumina is classified in the Health Care sector (Life Sciences Tools industry).
How can PortView help analyze ILMN in a portfolio?
PortView shows ILMN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.